Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

SHA:600993 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	590.51	581.49	528.09	443.25	478.57	464.59
Depreciation & Amortization	85.79	85.79	81	80.56	78.51	68.57
Other Amortization	12.58	12.58	5.64	9.52	9.83	9.22
Loss (Gain) From Sale of Assets	0.09	0.09	-0.02	-5.65	0.29	0.79
Asset Writedown & Restructuring Costs	7.41	7.41	5.4	0.09	0.06	0.15
Loss (Gain) From Sale of Investments	-33.85	-33.85	-13.81	-91.91	-2.86	-54.31
Provision & Write-off of Bad Debts	5.6	5.6	8.27	3.93	9.93	3.06
Other Operating Activities	110.3	33.98	30.63	35.36	18.52	26.47
Change in Accounts Receivable	-191.45	-191.45	-193.98	148.03	-356.2	231.67
Change in Inventory	-44.36	-44.36	-8.7	55.32	-26.26	-46.37
Change in Accounts Payable	148.52	148.52	61.32	-75.45	137.86	-105.32
Change in Other Net Operating Assets	-	-	-	-1.12	-0.77	-0.32
Operating Cash Flow	685.77	600.44	497.61	604.07	341.85	597.17
Operating Cash Flow Growth	15.94%	20.66%	-17.62%	76.70%	-42.75%	111.02%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-89.61	-119.37	-203.85	-248.36	-75.01	-65.1
Sale of Property, Plant & Equipment	0.5	0.5	0.92	3.61	0.46	0.58
Divestitures	0.45	0.45	-	-0.56	-	4
Investment in Securities	-756.3	-743.36	-60.72	675.91	-574.13	-36.59
Other Investing Activities	0.07	0.07	-	17.68	29.92	34.07
Investing Cash Flow	-844.89	-861.72	-263.65	448.27	-618.76	-63.05

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	-	78
Long-Term Debt Issued	-	14	44.6	58.6	488.31	-
Total Debt Issued	14	14	44.6	58.6	488.31	78
Short-Term Debt Repaid	-	-	-	-	-	-123
Long-Term Debt Repaid	-	-186.27	-91.91	-429.95	-127.47	-32.81
Total Debt Repaid	-166.37	-186.27	-91.91	-429.95	-127.47	-155.81
Net Debt Issued (Repaid)	-152.37	-172.27	-47.31	-371.35	360.84	-77.81
Common Dividends Paid	-269.53	-269.65	-177.28	-162.71	-165.04	-124.5
Other Financing Activities	-33.57	-39.46	-50.74	-45.1	-17.62	32.66
Financing Cash Flow	-455.47	-481.38	-275.33	-579.16	178.18	-169.64

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.45	-0.2	0.24	0.26	1.24	-0.6
Net Cash Flow	-615.05	-742.87	-41.13	473.43	-97.49	363.88

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	596.17	481.07	293.76	355.7	266.84	532.07
Free Cash Flow Growth	51.32%	63.76%	-17.41%	33.30%	-49.85%	123.96%
Free Cash Flow Margin	15.25%	12.44%	7.88%	11.34%	7.55%	15.72%
Free Cash Flow Per Share	1.38	1.12	0.68	0.83	0.62	1.24
Levered Free Cash Flow	253.37	74.41	191.59	129.78	263.3	281.25
Unlevered Free Cash Flow	257.87	79.02	196.2	140.32	270.61	287.63

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	343.71	310.83	328.43	323.88	308.24	288.92
Change in Working Capital	-92.66	-92.66	-147.61	128.91	-251	78.63

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error